Author:
Wang Xin,Huang Yubei,Li Lian,Dai Hongji,Song Fengju,Chen Kexin
Funder
China Postdoctoral Science Foundation Grant
The Doctor Start-up Grant of Tianjin Medical University Cancer Institute and Hospital
National Nature Science Foundation of China
Chinese National Key Scientific and Technological Project
National Natural Science Foundation of China
Tianjin Municipal Key Health Research Program grant
The Science&Technology Development Fund of Tianjin Education Commission for Higher Education
Program for Changjiang Scholars and Innovative Research Team in University in China
Publisher
Springer Science and Business Media LLC
Reference86 articles.
1. GLOBOCAN: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/summary_table_pop_sel.aspx . Accessed 31 Jun 2017.
2. Breast Cancer Risk Assessment Tool. National Cancer Institute. 2011. https://www.cancer.gov/bcrisktool/ . Accessed 13 Aug 2017.
3. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879–86.
4. Anderson SJ, Ahnn S, Duff K. NSABP Breast Cancer Prevention Trial risk assessment program, version 2. NSABP Biostatistical Center Technical Report. 1992.
5. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371–88.
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献